Back To Schedule
Tuesday, March 14 • 11:30am - 12:15pm
Panel: Search and Evaluation Strategies for Choosing the Right Business Partner to Advance Innovation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
  • Analyzing the company’s portfolio and underlying business goals and identifying gaps for growth
  • Evaluating different operating models for search and evaluation
  • Factors to take into consideration when selecting a partner
  • Creating alignment between partners to ensure a successful collaboration

avatar for Craig Farrell

Craig Farrell

GTM Director, Life Sciences, AlphaSense
Craig Farrell is a member of the Go-To-Market Strategy team at AlphaSense with responsibilities for both the Life Science vertical, as well as the enterprise search offering termed Internal Insights. He began his career in a Molecular Cytology research lab at Memorial Sloan Kettering... Read More →

avatar for Ravi Kiron, PhD, MBA

Ravi Kiron, PhD, MBA

Head, BioPharma External Innovation, EMD Serono, Inc.
Dr. Ravi Kiron based in California, USA is an experienced pharma/biotech executive with decades of experience in discovery R&D through late-stage clinical development, intellectual property and regulatory, technology & business development, M&A, strategy and product commercialization... Read More →
avatar for Dominic McDonald, MBA

Dominic McDonald, MBA

Senior Director, Search & Evaluation, Oncology R&D Business Development, AstraZeneca
Dominic is currently a Senior Director, Search & Evaluation within AstraZeneca’s Oncology R&D Business Development group. Selected transactions that Dominic has completed include the licensing of TNB-486 (CD19/CD3 BiSpecific) from TeneoBio as well as the acquisition of Neogene Therapeutics... Read More →
avatar for Garrett Rhyasen, PhD

Garrett Rhyasen, PhD

Vice President, Head of Search, Evaluation, and Transactions, GSK
Garrett Rhyasen is Vice President of Oncology Search & Evaluation at GSK, where he leads a team of BD professionals responsible for sourcing, technical evaluation, and business case delivery of partnering opportunities.Prior to GSK, Garrett was Executive Director of and Global Head... Read More →
avatar for Nikhil Mutyal, PhD

Nikhil Mutyal, PhD

Executive Director, Business Development and Licensing, Merck
Nikhil Mutyal, Ph.D. is Executive Director, Business Development and Licensing in Pacific Hub for Merck and Co (known as MSD outside of United States) based in San Francisco. Dr. Mutyal leads BD&L efforts for Oncology, Neuroscience and Cardiometabolic diseases for therapeutic opportunities... Read More →

Tuesday March 14, 2023 11:30am - 12:15pm PDT
Hyatt Centric Fisherman's Wharf San Francisco